GovChime
Notice ID: 52d1a274ef7e459c8a725f14f01a5048Combined Synopsis/SolicitationArchived

Evaluating the utility of bulk RNA transcriptomics

Archived on July 17, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EDT
Posted
July 10, 2025
Notice type
Combined Synopsis/Solicitation
Set-aside
No Set aside used
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Place of performance
Silver Spring, 20993
Last updated
Nov 11, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
FDA-CDER-25-128751
Notice ID
52d1a274ef7e459c8a725f14f01a5048

Description

The objective of this contract is to obtain service required to complete bulk transcriptomics of RNAs from treated and untreated primary liver hepatocytes. Transcriptomics data generated from bulk RNA sequencing will identify changes occurring for both coding and noncoding RNAs in primary human hepatocytes (PHHs) following treatment. Obtain the service required to complete bulk RNA sequencing or transcriptomics from treated primary liver hepatocytes (PHHS). Transcriptomics data generated from bulk RNA sequencing will quantify expression of both coding and noncoding RNAs in PHHs.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (5)

  • Contractor Questions and Answers FDA-CDER-25-128751_07102025.pdf

    127 KBAdded in Combined Synopsis/Solicitation version 4Posted
    Download
  • Contractor Questions and Answers FDA-CDER-25-128751.pdf

    66 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • Other_Attachment No. 2 - HHS Class Deviation.pdf

    107 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • Other_Attachment No. 1 - FAR Class Deviation.pdf

    316 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • RFQ CDER-25-128751 Genomic Services .pdf

    456 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/SolicitationArchived

    Evaluating the utility of bulk RNA transcriptomics

    Notice ebd4756deaef4990a822e050082eaf7f on SAM.gov

  2. 2
    Version 2Combined Synopsis/SolicitationArchived

    Evaluating the utility of bulk RNA transcriptomics

    Notice b639aaad194147b7a262d331ccdeaedc on SAM.gov

  3. 4
    Version 4Combined Synopsis/SolicitationArchivedCurrent

    Evaluating the utility of bulk RNA transcriptomics

    Notice 52d1a274ef7e459c8a725f14f01a5048 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDA-CDER-25-128751

Archive Date

Jul 17, 2025